Akacia Healthcare

Akacia Healthcare is a leading South African pharmaceutical company focused on the development, manufacturing, and distribution of high-quality branded and generic medicines. The company maintains a significant presence in the over-the-counter (OTC) and prescription markets, with core strengths in therapeutic areas such as gastrointestinal health, pain management, and respiratory care. Akacia operates a sophisticated, GMP-certified manufacturing facility in Gauteng, South Africa, which enables it to produce a variety of dosage forms including liquids and semi-solids. In January 2017, Akacia was acquired by the UK-based Clinigen Group for approximately £45 million, positioning it as a strategic platform for Clinigen's expansion into the Sub-Saharan African market. Today, the company continues to provide essential healthcare products while leveraging its parent company's global supply chain and clinical services expertise.